Sign Out
Before starting treatment, the patient should be informed of possible eye color changes; observe eye color changes; aphakia or pseudophakia with a tear in the posterior lens capsule or anterior lens space; risk factors for cystoid macular edema; severe or recurrent asthma; should not be used within 5 minutes after using preparations containing thyomersal; pregnancy.
Should not be used in women who are breastfeeding.
The potential for heterochromia exists in patients receiving a single treatment.
Lanjutkan dengan Google